Functional Roles of NKp46 in Transplantation
NKp46 在移植中的功能作用
基本信息
- 批准号:8460369
- 负责人:
- 金额:$ 22.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-09 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAlloantigenAllograftingCell CommunicationCell physiologyCellsChronicCytolysisDendritic CellsDevelopmentDown-RegulationEffector CellEquilibriumFamilyGerm LinesGoalsGraft RejectionGraft ToleranceHost DefenseImmuneImmune responseImmune systemImmunologic MonitoringInfluenzaInjection of therapeutic agentLeadLigandsLymphocyteMediatingMusNK Cell ActivationNatural ImmunityNatural Killer CellsOrgan TransplantationOutcomeParticipantPopulationPredispositionProtein IsoformsReceptor ActivationRegulationRoleSequence AnalysisSignal TransductionSiteSolidTestingTransplantationallograft rejectioncell transformationcytotoxiccytotoxicitydesignimmune functionimmunological synapseimprovedinnovationmembernatural killer cell protein 44-kDapathogenpreventpublic health relevancereceptorresearch studyresponsetumor
项目摘要
DESCRIPTION (provided by applicant): Natural killer (NK) cells are effector cells of the innate immune system that can lyse target cells without prior sensitization, and have an important role in host defense to pathogens and transformed cells. NK cell function is controlled by a balance of negative and positive signals transmitted via germ-line encoded inhibitory and activating receptors. Although the concept of "missing-self" would suggest NK cells could target foreign allografts, the prevailing dogma has been that NK cells are not active participants in the mechanisms that culminate in graft rejection. Recent studies, however, challenge this conclusion and instead implicate NK cells in both acute and chronic allograft rejection. Quite paradoxically, NK cells have also been shown to facilitate tolerance to an allograft. To reconcile these disparate observations we hypothesized that NK cells, through expression and function of activating receptors, regulate other cells of the immune system especially dendritic cells (DC). Indeed we have demonstrated that DC- mediated activation of NK cells is dependent upon signaling through the NKp46 activation receptor. The goal of this exploratory/developmental proposal is to determine how NK interactions regulate the adaptive immune response after transplantation. We propose two integrated Specific Aims: 1) determine the phenotypic and functional features of NK cells after transplantation and 2) determine how NKp46 contributes to the function of NK cells post-transplant, to test our hypothesis that NKp46 is important in regulating NK-mediated immune functions post-transplant. Our innovative study will have important implications in designing strategies to prevent graft rejection and promote tolerance to an allograft.
描述(由申请人提供):自然杀伤(NK)细胞是先天免疫系统的效应细胞,无需事先致敏即可裂解靶细胞,在宿主防御病原体和转化细胞中发挥重要作用。 NK 细胞功能由通过种系编码的抑制性和激活性受体传递的负信号和正信号的平衡控制。尽管“自我缺失”的概念表明 NK 细胞可以靶向外源同种异体移植物,但普遍的教条是 NK 细胞并不是最终导致移植物排斥的机制的积极参与者。然而,最近的研究对这一结论提出了质疑,并认为 NK 细胞与急性和慢性同种异体移植排斥有关。相当矛盾的是,NK 细胞也被证明可以促进对同种异体移植物的耐受。为了协调这些不同的观察结果,我们假设 NK 细胞通过激活受体的表达和功能来调节免疫系统的其他细胞,特别是树突状细胞 (DC)。事实上,我们已经证明 DC 介导的 NK 细胞激活依赖于通过 NKp46 激活受体的信号传导。该探索性/开发提案的目标是确定 NK 相互作用如何调节移植后的适应性免疫反应。我们提出了两个综合的具体目标:1)确定移植后 NK 细胞的表型和功能特征,2)确定 NKp46 如何促进移植后 NK 细胞的功能,以检验我们的假设,即 NKp46 在调节 NK 介导的过程中很重要移植后的免疫功能。我们的创新研究将对设计预防移植排斥和促进同种异体移植耐受的策略具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sheri M. Krams其他文献
Sheri M. Krams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sheri M. Krams', 18)}}的其他基金
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
- 批准号:
10755055 - 财政年份:2023
- 资助金额:
$ 22.19万 - 项目类别:
Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients
外泌体和儿科移植受者同种异体移植结果中的免疫反应
- 批准号:
10612125 - 财政年份:2022
- 资助金额:
$ 22.19万 - 项目类别:
Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients
外泌体和儿科移植受者同种异体移植结果中的免疫反应
- 批准号:
10339207 - 财政年份:2021
- 资助金额:
$ 22.19万 - 项目类别:
Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients
外泌体和儿科移植受者同种异体移植结果中的免疫反应
- 批准号:
10188897 - 财政年份:2020
- 资助金额:
$ 22.19万 - 项目类别:
Plasmacytoid Dendritic Cell microRNAS in Transplantation
浆细胞样树突状细胞 microRNAS 在移植中的应用
- 批准号:
9302655 - 财政年份:2016
- 资助金额:
$ 22.19万 - 项目类别:
Tolerance Induction and Viral Infection in Liver Transplantation
肝移植中的耐受诱导和病毒感染
- 批准号:
8084888 - 财政年份:2010
- 资助金额:
$ 22.19万 - 项目类别:
IMMUNE-MEDIATED BILE DUCT INJURY IN BILIARY ATRESIA
胆道闭锁中免疫介导的胆管损伤
- 批准号:
6091826 - 财政年份:2000
- 资助金额:
$ 22.19万 - 项目类别:
IMMUNE-MEDIATED BILE DUCT INJURY IN BILIARY ATRESIA
胆道闭锁中免疫介导的胆管损伤
- 批准号:
6381830 - 财政年份:2000
- 资助金额:
$ 22.19万 - 项目类别:
相似国自然基金
抗骨髓瘤的新型同种异体嵌合抗原受体T(CAR T)细胞疗法研发
- 批准号:82270210
- 批准年份:2022
- 资助金额:68 万元
- 项目类别:面上项目
TIGIT活化CD155信号促进调节性APC产生诱导异体复合组织移植免疫耐受的机制及应用研究
- 批准号:81901980
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
受体tolDC诱导的供体MHC-I抗原特异性Treg诱导同种异体器官移植免疫耐受
- 批准号:81901627
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
靶向Her3的人同种异体CAR-T的建立及其对肿瘤的杀伤作用
- 批准号:81802837
- 批准年份:2018
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
CTLA4通过非经典NF-κB信号通路诱导EC内IDO表达抑制异体复合组织移植排斥反应
- 批准号:81401615
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeted immune therapies in heart transplantation
心脏移植中的靶向免疫治疗
- 批准号:
10573846 - 财政年份:2023
- 资助金额:
$ 22.19万 - 项目类别:
Engineering synthetic cellular crosstalk for transplantation tolerance
工程合成细胞串扰以实现移植耐受
- 批准号:
10557904 - 财政年份:2022
- 资助金额:
$ 22.19万 - 项目类别:
Requirements and mechanisms of alloantigen-induced cardiac allograft survival by cDC1s
cDC1同种异体抗原诱导心脏同种异体移植物存活的要求和机制
- 批准号:
10744193 - 财政年份:2022
- 资助金额:
$ 22.19万 - 项目类别:
Engineering synthetic cellular crosstalk for transplantation tolerance
工程合成细胞串扰以实现移植耐受
- 批准号:
10295388 - 财政年份:2022
- 资助金额:
$ 22.19万 - 项目类别: